Table 2

 Clinical data of all RYR2 mutation carriers

RYR2 CPVT
*Median (range).
VT/VF, ventricular tachycardia/ventricular fibrillation.
Number of probands12
Total no. of mutation carriers54
Families with juvenile sudden death7/12 (58%)
Age of onset all carriers, years12 (4–51)*
Clinically affected39
Phenotype undetermined4
Silent gene carrier11
Gender32F/22M
Exercise related syncope26/54 (48%)
Patients on β blockers50/54
Follow up, years2 (2–37)*
VT/VF on β blockers1/50